| Attribute |
Value |
| 52 Week Change |
0.026850224 |
| Address1 |
Glenpointe Centre East |
| Address2 |
3rd Floor Suite 21 300 Frank West Burr Boulevard |
| All Time High |
60.08 |
| All Time Low |
9.4 |
| Ask |
48.0 |
| Ask Size |
2 |
| Audit Risk |
9 |
| Average Analyst Rating |
3.0 - Hold |
| Average Daily Volume10 Day |
239,290 |
| Average Daily Volume3 Month |
266,450 |
| Average Volume |
266,450 |
| Average Volume10Days |
239,290 |
| Beta |
0.463 |
| Bid |
26.47 |
| Bid Size |
2 |
| Board Risk |
10 |
| Book Value |
9.503 |
| City |
Teaneck |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Compensation Risk |
6 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
37.67 |
| Current Ratio |
2.956 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,786,665,600 |
| Day High |
38.65 |
| Day Low |
36.36 |
| Debt To Equity |
206.406 |
| Display Name |
Phibro Animal Health |
| Dividend Date |
1,790,121,600 |
| Dividend Rate |
0.48 |
| Dividend Yield |
1.32 |
| Earnings Call Timestamp End |
1,787,835,600 |
| Earnings Call Timestamp Start |
1,787,835,600 |
| Earnings Growth |
0.246 |
| Earnings Quarterly Growth |
0.26 |
| Earnings Timestamp |
1,787,774,400 |
| Earnings Timestamp End |
1,793,822,400 |
| Earnings Timestamp Start |
1,793,822,400 |
| Ebitda |
244,231,008 |
| Ebitda Margins |
0.16088 |
| Enterprise To Ebitda |
9.176 |
| Enterprise To Revenue |
1.476 |
| Enterprise Value |
2,241,127,424 |
| Eps Current Year |
3.50127 |
| Eps Forward |
3.85044 |
| Eps Trailing Twelve Months |
2.52 |
| Esg Populated |
0 |
| Ex Dividend Date |
1,788,307,200 |
| Exchange |
NGM |
| Exchange Data Delayed By |
0 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
34.1269 |
| Fifty Day Average Change |
3.5430984 |
| Fifty Day Average Change Percent |
0.10382128 |
| Fifty Two Week Change Percent |
2.6850224 |
| Fifty Two Week High |
60.08 |
| Fifty Two Week High Change |
-22.410004 |
| Fifty Two Week High Change Percent |
-0.3730027 |
| Fifty Two Week Low |
28.25 |
| Fifty Two Week Low Change |
9.419998 |
| Fifty Two Week Low Change Percent |
0.33345127 |
| Fifty Two Week Range |
28.25 - 60.08 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,397,223,000,000 |
| Five Year Avg Dividend Yield |
2.55 |
| Float Shares |
20,891,961 |
| Forward Eps |
3.85044 |
| Forward P E |
9.783297 |
| Free Cashflow |
-19,298,000 |
| Full Exchange Name |
NasdaqGM |
| Full Time Employees |
2,605 |
| Fullday Change |
1.32 |
| Fullday Change Percent |
3.63136 |
| Fullday Price |
36.76 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Governance Epoch Date |
1,785,542,400 |
| Gross Margins |
0.33328998 |
| Gross Profits |
505,971,008 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.00866 |
| Held Percent Institutions |
1.03791 |
| Implied Shares Outstanding |
40,601,603 |
| Industry |
Drug Manufacturers - Specialty & Generic |
| Industry Disp |
Drug Manufacturers - Specialty & Generic |
| Industry Key |
drug-manufacturers-specialty-generic |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Dividend Date |
1,780,444,800 |
| Last Dividend Value |
0.12 |
| Last Fiscal Year End |
1,782,777,600 |
| Long Business Summary |
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey. |
| Long Name |
Phibro Animal Health Corporation |
| Market |
us_market |
| Market Cap |
1,529,462,400 |
| Market State |
CLOSED |
| Max Age |
86,400 |
| Message Board Id |
finmb_528955 |
| Most Recent Quarter |
1,782,777,600 |
| Net Income To Common |
99,720,000 |
| Next Fiscal Year End |
1,814,313,600 |
| Non Diluted Market Cap |
1,475,868,268 |
| Number Of Analyst Opinions |
5 |
| Open |
36.36 |
| Operating Cashflow |
68,954,000 |
| Operating Margins |
0.106429994 |
| Overall Risk |
10 |
| Payout Ratio |
0.1975 |
| Peg Ratio |
1.68 |
| Phone |
201 329 7300 |
| Post Market Change |
-0.90999985 |
| Post Market Change Percent |
-2.4157152 |
| Post Market Price |
36.76 |
| Post Market Time |
1,787,959,806 |
| Previous Close |
36.35 |
| Price Eps Current Year |
10.758952 |
| Price Hint |
2 |
| Price To Book |
3.964011 |
| Price To Sales Trailing12 Months |
1.0074892 |
| Profit Margins |
0.065689996 |
| Quick Ratio |
1.02 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
hold |
| Recommendation Mean |
3.0 |
| Region |
US |
| Regular Market Change |
1.32 |
| Regular Market Change Percent |
3.63136 |
| Regular Market Day High |
38.65 |
| Regular Market Day Low |
36.36 |
| Regular Market Day Range |
36.36 - 38.65 |
| Regular Market Open |
36.36 |
| Regular Market Previous Close |
36.35 |
| Regular Market Price |
37.67 |
| Regular Market Time |
1,787,947,200 |
| Regular Market Volume |
362,747 |
| Return On Assets |
0.08483 |
| Return On Equity |
0.29716 |
| Revenue Growth |
0.048 |
| Revenue Per Share |
37.441 |
| Sand P52 Week Change |
0.20204377 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Share Holder Rights Risk |
10 |
| Shares Outstanding |
21,105,569 |
| Shares Percent Shares Out |
0.0304 |
| Shares Short |
1,233,227 |
| Shares Short Previous Month Date |
1,784,073,600 |
| Shares Short Prior Month |
1,218,445 |
| Short Name |
Phibro Animal Health Corporatio |
| Short Percent Of Float |
0.0696 |
| Short Ratio |
6.14 |
| Source Interval |
15 |
| State |
NJ |
| Symbol |
PAHC |
| Target High Price |
55.0 |
| Target Low Price |
35.0 |
| Target Mean Price |
44.0 |
| Target Median Price |
44.0 |
| Total Cash |
83,983,000 |
| Total Cash Per Share |
2.068 |
| Total Debt |
795,648,000 |
| Total Revenue |
1,518,093,056 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.48 |
| Trailing Annual Dividend Yield |
0.013204952 |
| Trailing Eps |
2.52 |
| Trailing P E |
14.948412 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
42.02335 |
| Two Hundred Day Average Change |
-4.3533516 |
| Two Hundred Day Average Change Percent |
-0.10359363 |
| Type Disp |
Equity |
| Volume |
362,747 |
| Website |
https://www.pahc.com |
| Zip |
07,666-6712 |